SH

Stephen Hill

Chief Technical Officer

Lyell Immunopharma

Seattle, Washington


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Lyell Immunopharma
Industry
research
Employees
280.0
Seniority
C suite
Annual Revenue
63000.0

Professional Summary

Stephen Hill serves as Chief Technical Officer at Lyell Immunopharma. Lyell Immunopharma operates in the research sector with approximately 280.0 employees. The company is headquartered in Seattle, Washington. Lyell Immunopharma generates annual revenue of 63000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • 2,277 executive contacts are available in Washington.
  • Our database includes 201,469 c suite-level executives.

Technologies

Route 53 Outlook Amazon AWS Zendesk Atlassian Cloud Google Tag Manager Google Font API Mobile Friendly Greenhouse.io New Relic Remote

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research t-cell therapy car t-cell cell reprogramming immunotherapy solid tumors hematologic malignancies dual-targeting exhaustion resistance stemness enhancement clinical trials b-cell lymphoma ovarian cancer endometrial cancer triple-negative breast cancer non-small cell lung cancer cd19 cd20 ror1 patient-derived t cells antitumor activity cytokine production personalized therapy genetic reprogramming epigenetic reprogramming lyfe manufacturing center c-jun nr4a3 tumor-infiltrating lymphocytes t-cell receptor therapy long-lasting clinical response novel technology patient safety clinical data treatment protocols manufacturing process open-label study fast track designation central memory t cells immunosuppressive tumor microenvironment t-cell function antigen escape oncology research & development biopharmaceutical therapeutic products molecular engineering cell-based therapy scientific innovation digital manufacturing platform real-time monitoring biotechnology cell therapy car t-cell therapy cancer treatment innovative therapies patient-centric cd19/cd20 durable responses transformative medicine proprietary technology regenerative medicine advanced therapy (rmat) patient outcomes healthcare providers research institutions collaborations personalized treatment unmet medical needs advanced protein engineering durable tumor cytotoxicity cancer patients oncologists research partnerships global reach innovative science compassionate care excellence in therapy development health wellness & fitness hospital & health care

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Frequently Asked Questions

How can I contact Stephen Hill?

Stephen Hill's verified email address is available on MessageCEO. They currently work at Lyell Immunopharma. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Stephen Hill lead?

Stephen Hill is Chief Technical Officer at Lyell Immunopharma, a company in the research sector with 280.0 employees. The company is based in Seattle, Washington.

What industry is Stephen Hill in?

Stephen Hill works in the research industry as Chief Technical Officer at Lyell Immunopharma. MessageCEO provides verified contact information for executives across all major industries.

Is Stephen Hill's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Stephen Hill's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 7, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans